Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 37Lung Neoplasms 21Brain Neoplasms 21Prostatic Neoplasms 20Pancreatic Neoplasms 20Neoplasm Metastasis 20Carcinoma, Hepatocellular 17Melanoma 15Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Small Cell Lung Carcinoma 6Liver Neoplasms 6Glioblastoma 6Sarcoma 5Head and Neck Neoplasms 4Salivary Gland Neoplasms 3Recurrence 3Kidney Neoplasms 3Gliosarcoma 3Glioma 3Colorectal Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma of Lung 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Ewing 2

Interventions

Pemetrexed 15Cisplatin 13pembrolizumab 6Platinum 41,2-diaminocyclohexaneplatinum II citrate 4cediranib 3Radiotherapy 3Gemcitabine 3Carboplatin 3amatuximab 2Radiotherapy, Intensity-Modulated 2Radiation 2Everolimus 2Drug Therapy 2Cyclophosphamide 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1sodium thiosulfate 1sargramostim 1nintedanib 1napabucasin 1methoxyamine 1liposomal doxorubicin 1incomplete Freund's adjuvant 1fresolimumab 1durvalumab 1defactinib 1cixutumumab 1bintrafusp alfa protein, human 1bemcentinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mesothelioma, Malignant × Radiosurgery × Clear all
NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
15 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡